News about Special product areas

  • New chair of PhVWP-V

    | 20 December 2016 |

    Lisbet Vesterager Borge, veterinarian, has been elected chair of the European Pharmacovigilance Working Party Veterinary (PhVWP-V).

  • Zinc oxide for young pigs to be phased out

    | 19 December 2016 |

    The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has recommended to the European Commission that medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs should be withdrawn from the market.

  • Marketing authorisation for medicine for cows suspended in the EU/EEA

    | 20 July 2016 |

    On 14 July 2016, the Committee for Medicinal Products for Veterinary Use (CVMP) recommended that the marketing authorisation for the centrally authorised medicinal product Velactis (cabergoline) be suspended temporarily. Velactis is used to reduce milk production in dairy cows at the time of drying off. The recommendation follows reports of serious adverse events after treatment with Velactis.

  • Use of medicine for cows suspended

    | 21 June 2016 |

    Today, the Danish Medicines Agency has decided to suspend the use of the veterinary medicine Velactis, which is used to reduce milk production (drying-off) in dairy cows.

  • Updated list of biological medicinal products

    | 04 February 2016 |

    The Danish Medicines Agency has added five new medicinal products to the list of biological and biosimilar medicinal products.

  • The Danish Medicines Agency has a new website

    | 04 January 2016 |

    Today, the Danish Medicines Agency launched its new website – laegemiddelstyrelsen.dk/en – where you can read about and subscribe to news about licensing and supervision of medicines, side effects, reimbursement, pharmacies and medical devices.